/Agilent%20Technologies%20Inc_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Valued at a market cap of $34.2 billion, Agilent Technologies, Inc. (A) provides application focused solutions to the life sciences, diagnostics, and applied chemical markets. The Santa Clara, California-based company provides laboratories with instruments, software, services, consumables, and expertise, ranging from chromatography and mass spectrometry to genomics, diagnostics, cell analysis, and digital lab optimization.
Companies valued at $10 billion or more are typically classified as “large-cap stocks,” and Agilent Technologies fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the diagnostics & research industry. The company’s key strengths lie in its strong R&D capabilities, global market presence, and diversified product portfolio. With a presence in over 100 countries, it combines scientific innovation with digital lab optimization to deliver high accuracy, efficiency, and reliability, making it a trusted partner for laboratories worldwide.
